Stem cells from umbilical cord blood is preserved as it has capabilities of regenerating into any type of body cells. In life threatening malignant and non-malignant diseases, hematopoietic stem cells transplantation (HSCT) can help in saving the life of person. In addition, the therapy is comparatively cost effective and has limited side effects. Umbilical stem cells are used for treating cancer, blood diseases like anemia and certain immune system disorders.
MARKET SCOPE
The "Global Stem Cell Umbilical Cord Blood (UCB) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the stem cell umbilical cord blood (UCB) market with detailed market segmentation by material, end user, and geography. The report provides key statistics on the market status of the leading stem cell umbilical cord blood (UCB) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on storage option, the market is bifurcated into private UCB banks and public UCB banks.
- On the basis of disease, the market is classified as bone marrow failure syndrome, immune deficiencies, leukemia, lymphoma, metabolic/storage diseases and other diseases.
MARKET DYNAMICS
Drivers:
- Increasing occurrence of chronic diseases as well as rising support of government
- Private sector for research and development
- Growing popularity for umbilical cord storage in developing countries
Restraints:
- Legal and ethical issues during collection
- Higher cost of therapies
- Unavailability of suitable matched donor
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The stem cell umbilical cord blood (UCB) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the stem cell umbilical cord blood (UCB) market in these regions.
IMPACT OF COVID-19 ON STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the stem cell umbilical cord blood (UCB) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from stem cell umbilical cord blood (UCB) market are anticipated to lucrative growth opportunities in the future with the rising demand for stem cell umbilical cord blood (UCB) in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the stem cell umbilical cord blood (UCB) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- CBR Systems, Inc.
- Cordlife Sciences India Pvt. Ltd.
- Cryo-Cell International, Inc.
- CryoSave
- Cryoviva India
- Global Cord Blood Corporation
- Lifecell
- Regrow Biosciences Pvt. Ltd.
- Smart Cells International Ltd.
- ViaCord